• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Australia·Healthcare·HIQ.AX
Share

HITIQ Limited Stocks

A$ 0.01Last Updated 28.07.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

A$ 2.77M

A$ 0.01
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

HITIQ Limited is an Australian enterprise focused on developing and commercializing advanced technology for concussion management. Its Nexus software platform delivers comprehensive data and analytical insights concerning head impacts, empowering informed decision-making to enhance care for athletes. The company also offers CoVR, a virtual reality-based system for assessing cognitive and oculomotor functions, capable of identifying impairments in areas such as hand-eye coordination, memory, and critical thinking. Additionally, CSX provides a straightforward sideline tool for concussion evaluation, generating digital records that can be easily shared with medical professionals, family members, and organizations to ensure coordinated athlete support. Established in 2015, the company maintains its headquarters in Melbourne, Australia.

Company Valuation

Slightly overvalued
3/7

Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

30.07.2026 17:35

Egypt reported a drone attack on ships in a Mediterranean port

30.07.2026 17:11

The fund run by the 24-year-old “AI Nostradamus” needed new capital following the tech sector’s downturn

30.07.2026 16:50

Shares of the micro-cap biotech company Processa plummeted following the announcement of a merger. What went wrong?

30.07.2026 16:15

Opinion: The AI Boom vs. the Dot-Com Era. What Are Their Main Differences?

30.07.2026 15:50

July Could Be the Worst Month for Chinese Stocks in 10 Years

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026